Kovid 19 Haberleri


        
 
Haber:
Etiketler:
Yazarın adı:
Yazarın soyadı:


30 Ekim 2021, Cumartesi, 00:08 Outbreak Associated with SARS-CoV-2 B.1.617.2 (Delta) Variant in an Elementary School - Marin County, California, May-June 2021
COVID-19 outbreak associated with an unvaccinated infected teacher in an elementary school from May-June 2021 in Marin County, California.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=426261


30 Ekim 2021, Cumartesi, 00:08 Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years, - COVID-NET, 13 States, February-April 2021
This report describes COVID-19 vaccine effectiveness in adults aged 65 years and older.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425574


30 Ekim 2021, Cumartesi, 00:08 Rapid Increase in Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - Mesa County, Colorado, April-June 2021
This report describes an increase in Delta variant cases of COVID-19 in Mesa County, Colorado.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425571


30 Ekim 2021, Cumartesi, 00:08 Multiple Variants of SARS-CoV-2 in a University Outbreak After Spring Break - Chicago, Illinois, March-May 2021
This report describes an influx of COVID-19 cases at Chicago University following spring break 2021.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=426420


30 Ekim 2021, Cumartesi, 00:08 Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021
ACIP reviewed information on COVID-19 vaccines and concluded that benefits of vaccination outweigh the risks of rare, serious adverse events.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425616


30 Ekim 2021, Cumartesi, 00:08 Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021
mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection was 90% for full immunization (≥14 days after second dose) and 80% for partial immunization (≥14 days after first dose but before second dose) in real-world conditions.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=419354


30 Ekim 2021, Cumartesi, 00:08 Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021
This report describes COVID-19 outbreaks associated with large public gatherings in Massachusetts.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425231


30 Ekim 2021, Cumartesi, 00:08 Symptoms of Anxiety or Depressive Disorder and Use of Mental Health Care Among Adults During the COVID-19 Pandemic - United States, August 2020-February 2021
From August 2020-February 2021, adults with recent symptoms of an anxiety or depressive disorder increased from 36% to 42%. Increases were largest among adults 18-29 years and those with less than a high school education.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=419353


30 Ekim 2021, Cumartesi, 00:08 COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021
This report describes COVID-19 vaccine safety among U.S. adolescents aged 12-17 years.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=425230


30 Ekim 2021, Cumartesi, 00:08 Mental Health and Substance Use Among Adults with Disabilities During the COVID-19 Pandemic - United States, February-March 2021
This report describes adverse mental health symptoms or substance use among adults with disabilities during the COVID-19 pandemic.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=426176